or
forgot password

    • cancer clinical trials in burlington, VT

    • Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Pancreatic Cancer
    Irinotecan in Treating Aging Patients With Solid Tumors
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Unspecified Adult Solid Tumor, Protocol Specific
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain Tumor, Central Nervous System Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Brain and Central Nervous System Tumors
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
    Burlington, Vermont 05401
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Cervical Cancer
    Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Carcinoma, Metastatic Breast
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lymphoma
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Colorectal Cancer, Neoplasm Metastasis
    Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Kidney Cancer
    CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Carcinoma, Breast
    Genetic Study of Young Patients With Colorectal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Colorectal Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Breast Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Carcinoma of Unknown Primary
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Colorectal Cancer, Diarrhea, Neutropenia
    Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Cutaneous Melanoma
    Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia, Lymphoma
    Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Prostate Cancer
    Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia, Lymphoma
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Prostate Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Malignant Mesothelioma
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Brain Tumor, Central Nervous System Tumors, Cachexia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Unspecified Childhood Solid Tumor, Protocol Specific
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoproliferative Disorder
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lung Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain and Central Nervous System Tumors
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Kidney Cancer
    Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
    University of Vermont/Fletcher Allen Healthcare
    Burlington, Vermont 05401
    Glioblastoma Multiforme
    Trial of rPA-102 Vaccine in Healthy Adult Volunteers
    University of Vermont College of Medicine, Vermont Vaccine Evaluation Center
    Burlington, Vermont 05405
    Anthrax
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain and Central Nervous System Tumors
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Colorectal Neoplasms
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Sarcoma
    Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Cancer Cachexia
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Carcinoma, Non-Small-Cell Lung
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Fletcher Allen Health Care
    Burlington, Vermont 05401
    Carcinoma, Non-Small-Cell Lung
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Brain and Central Nervous System Tumors
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Neuroblastoma
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Colorectal Cancer
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Fletcher Allen Health Care-Medical Center
    Burlington, Vermont 05401
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Registration and Informed Consent Study for the Childhood Cancer Research Network
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Unspecified Childhood Solid Tumor, Protocol Specific
    Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lung Cancer